Mural Oncology Plc Stock Performance
| MURA Stock | 3.66 0.07 1.88% |
Mural Oncology has a performance score of 3 on a scale of 0 to 100. The company secures a Beta (Market Risk) of 0.51, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Mural Oncology's returns are expected to increase less than the market. However, during the bear market, the loss of holding Mural Oncology is expected to be smaller as well. Mural Oncology plc right now secures a risk of 3.45%. Please verify Mural Oncology plc semi variance, and the relationship between the maximum drawdown and accumulation distribution , to decide if Mural Oncology plc will be following its current price movements.
Risk-Adjusted Performance
Insignificant
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Mural Oncology plc are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Mural Oncology may actually be approaching a critical reversion point that can send shares even higher in April 2025. ...more
| Begin Period Cash Flow | 271.1 M |
Mural |
Mural Oncology Relative Risk vs. Return Landscape
If you would invest 344.00 in Mural Oncology plc on December 14, 2024 and sell it today you would earn a total of 24.00 from holding Mural Oncology plc or generate 6.98% return on investment over 90 days. Mural Oncology plc is currently generating 0.1699% in daily expected returns and assumes 3.4484% risk (volatility on return distribution) over the 90 days horizon. In different words, 30% of stocks are less volatile than Mural, and 97% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Mural Oncology Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mural Oncology's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Mural Oncology plc, and traders can use it to determine the average amount a Mural Oncology's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0493
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MURA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.45 actual daily | 30 70% of assets are more volatile |
Expected Return
| 0.17 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Mural Oncology is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Mural Oncology by adding it to a well-diversified portfolio.
Mural Oncology Fundamentals Growth
Mural Stock prices reflect investors' perceptions of the future prospects and financial health of Mural Oncology, and Mural Oncology fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Mural Stock performance.
| Return On Equity | -1.84 | ||||
| Return On Asset | -0.85 | ||||
| Current Valuation | (101.81 M) | ||||
| Shares Outstanding | 17.06 M | ||||
| Price To Book | 0.37 X | ||||
| EBITDA | (156.06 M) | ||||
| Total Debt | 8.02 M | ||||
| Book Value Per Share | 10.22 X | ||||
| Cash Flow From Operations | (128.54 M) | ||||
| Earnings Per Share | (7.58) X | ||||
| Total Asset | 169.39 M | ||||
| Retained Earnings | (159.37 M) | ||||
About Mural Oncology Performance
By analyzing Mural Oncology's fundamental ratios, stakeholders can gain valuable insights into Mural Oncology's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Mural Oncology has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Mural Oncology has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about Mural Oncology plc performance evaluation
Checking the ongoing alerts about Mural Oncology for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Mural Oncology plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Mural Oncology plc had very high historical volatility over the last 90 days | |
| Mural Oncology plc has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (128.51 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Mural Oncology generates negative cash flow from operations | |
| Mural Oncology plc has a frail financial position based on the latest SEC disclosures | |
| About 61.0% of the company shares are owned by institutional investors |
- Analyzing Mural Oncology's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Mural Oncology's stock is overvalued or undervalued compared to its peers.
- Examining Mural Oncology's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Mural Oncology's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Mural Oncology's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Mural Oncology's stock. These opinions can provide insight into Mural Oncology's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Mural Stock analysis
When running Mural Oncology's price analysis, check to measure Mural Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mural Oncology is operating at the current time. Most of Mural Oncology's value examination focuses on studying past and present price action to predict the probability of Mural Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mural Oncology's price. Additionally, you may evaluate how the addition of Mural Oncology to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Stocks Directory Find actively traded stocks across global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |